AJTMH Transactions of the Royal Society of Tropical Medicine and Hygiene
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 58(4), 1998, pp. 389-398
Copyright © 1998 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Butrapet, S
Right arrow Articles by Yasui, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butrapet, S
Right arrow Articles by Yasui, K
Related Collections
Right arrow Viral Encephalitis
Right arrow Zoonotic Diseases
Right arrow Flaviviruses
American Journal of Tropical Medicine and Hygiene, Vol 58, Issue 4, 389-398
Copyright © 1998 by American Society of Tropical Medicine and Hygiene

Research Articles


Neutralizing mechanism of a monoclonal antibody against Japanese encephalitis virus glycoprotein E

S Butrapet, J Kimura-Kuroda, DS Zhou, and K Yasui

The neutralization of Japanese encephalitis virus (JEV) was studied using JEV-specific neutralizing (NT) monoclonal antibody (MAb) 503 that recognizes the envelope glycoprotein. Analysis using radiolabeled JEV and observations by confocal laser microscopy and electron microscopy indicated that the NT and protection activities of MAb 503 did not result from the prevention of the first step of JEV infection, binding of virus to the cell surface. Treatment with MAb 503 strongly inhibited JEV-induced cell fusion and internalization of JEV into the cells, and resulted in enhanced release of JEV-RNA from the cells. These observations suggested that the NT activity of MAb 503 is involved in the later steps of JEV infection.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
M. Saito, K. Taira, K. Itokazu, and N. Mori
Recent Change of the Antigenicity and Genotype of Japanese Encephalitis Viruses Distributed on Okinawa Island, Japan
Am J Trop Med Hyg, October 1, 2007; 77(4): 737 - 746.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
M. Nawa, T. Takasaki, K.-I. Yamada, I. Kurane, and T. Akatsuka
Interference in Japanese encephalitis virus infection of Vero cells by a cationic amphiphilic drug, chlorpromazine
J. Gen. Virol., July 1, 2003; 84(7): 1737 - 1741.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society of Tropical Medicine and Hygiene.